
Currently out of the existing stock ratings of Adam Walsh, 80 are a BUY (85.11%), 12 are a HOLD (12.77%), 2 are a SELL (2.13%).
Analyst Adam Walsh, currently employed at ROTH, has had 67.01% of price targets met with an average potential upside of 41.26%, reached in 397 days on average. Previously, Adam Walsh worked at ROTH MKM.
Adam Walsh has documented 180 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 15-Sep-2026.
Analyst best performing recommendations are on VRTX (VERTEX PHARMACEUTICALS).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) on 7/18/2017. The price target of $154 was fulfilled within 1 day with a profit of $21.84 (16.53%), with a performance score of 165.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Nov-2020
$10
3 years 10 months 2 days ago
(19-Jan-2023)
0/3 (0%)
$6 (150.00%)
Buy Since 10-Aug-2020
$14
3 years 10 months 2 days ago
(19-Jan-2023)
0/2 (0%)
$8.11 (137.69%)
Buy Since 24-Jun-2019
$9
$25
3 years 10 months 2 days ago
(19-Jan-2023)
0/7 (0%)
$0.71 (8.56%)
Buy Since 04-Sep-2019
$11
$25
4 years 5 months 29 days ago
(23-May-2022)
0/5 (0%)
$6.9 (168.29%)
Buy Since 24-Jul-2017
$17
$17
4 years 5 months 29 days ago
(23-May-2022)
1/7 (14.29%)
$12.9 (314.63%)
115
Stocks Adam Walsh covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.
Which stock is Adam Walsh most bullish on?
Which stock is Adam Walsh most reserved on?
What Year was the first public recommendation made by Adam Walsh?